Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Apelin has inhibitory effect of endothelium-independent relaxation in the human internal mammary artery

Emine Kacar, Oktay Burma, Ihsan Serhatlioglu, Nazife Ulker, Ahmet Yardimci, Ayhan Uysal, Haluk Kelestimur.




Abstract
Cited by 0 Articles

Aim: Apelin has important effects on the circulatory system and heart. The main aim of this study was to investigate the effects
of apelin-13 on the contraction induced by norepinephrine (NE), and the endothelium-independent relaxation induced by sodium
nitroprusside (SNP) in human internal mammary artery (IMA) obtained from patients undergoing coronary artery bypass grafting
(CABG) surgery.
Material and Methods: IMA rings, obtained from patients undergoing CABG surgery, were suspended in isolated tissue baths
containing Krebs-Henseleit solution, which were continuously gassed with 95% O2 and 5% CO2 at 37°C.
Results: The IMA rings were pre-contracted with increasing concentrations of norepinephrine (NE 10-9–10-4 mol/l) and the
endothelium-independent relaxation responses to sodium nitroprusside (SNP) were studied. Apelin-13 (10 μM) caused a dosedependent
relaxation in NE pre-contracted IMA rings. Apelin also facilitated the endothelium-independent relaxation induced by
SNP.
Conclusion: According to the results, apelin facilitated the endothelium-independent relaxation and inhibited the contractile activity
of IMA. These results suggest that apelin may be a physiological agent against the deterioration of vascular elasticity caused by
endothelial damage especially in atherosclerotic cardiac patients and hypertensive patients.

Key words: Apelin; Nitroprusside; Internal Mammary Artery; Coronary Artery Bypass.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.